NRIX EPS Estimates
Nurix Therapeutics, Inc.
$24.86
+$1.19(+5.04%)
55
Overall
60
Value
54
Tech
52
Quality
Market Cap
$2.59B
Volume
524.52K
52W Range
$9.00 - $28.23
Target Price
$34.36
NRIX EPS estimates: the consensus estimate for Nurix Therapeutics, Inc.'s current fiscal year is -$2.69 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NRIX EPS Estimates
- EPS estimate, current quarter
- $-0.50
- EPS estimate, next quarter
- $-0.50
- EPS estimate, current year
- $-2.69
- EPS estimate, next year
- $-1.78
- EPS growth, 3-year
- +6.32%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.05 |
| 2024 | $-2.88 |
| 2023 | $-2.65 |
| 2022 | $-3.71 |
| 2021 | $-2.73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NRIX | $24.86 | +5.0% | 524.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nurix Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW